(Q38043582)

27 August 2017

title

Plant virus expression vectors set the stage as production platforms for biopharmaceutical proteins (English)

1 reference

27 August 2017

0 references

1 reference

Kathleen Laura Hefferon

series ordinal

1

1 reference

27 August 2017

language of work or name

English

0 references

publication date

1 November 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

433

1 reference

27 August 2017

issue

1

1 reference

27 August 2017

page(s)

1-6

1 reference

Amplicon-plus targeting technology (APTT) for rapid production of a highly unstable vaccine protein in tobacco plants

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Bioproduction of therapeutic proteins in the 21st century and the role of plants and plant cells as production platforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Use of viral vectors for vaccine production in plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Development of cowpea mosaic virus-based vectors for the production of vaccines in plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Expression of a recombinant chimeric protein of hepatitis A virus VP1-Fc using a replicating vector based on Beet curly top virus in tobacco leaves and its immunogenicity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Plant-made vaccine antigens and biopharmaceuticals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Production of heterologous proteins in plants: strategies for optimal expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

High-yield production of authentic human growth hormone using a plant virus-based expression system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Engineering viral expression vectors for plants: the 'full virus' and the 'deconstructed virus' strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Engineering cowpea mosaic virus RNA-2 into a vector to express heterologous proteins in plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Expression of a vaccine protein in a plant cell line using a geminivirus-based replicon system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

A DNA replicon system for rapid high-level production of virus-like particles in plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Improved expression of recombinant GFP using a replicating vector based on Beet curly top virus in leaf-disks and infiltrated Nicotiana benthamiana leaves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

The green revolution: plants as heterologous expression vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Rapid, high-level expression of biologically active alpha-trichosanthin in transfected plants by an RNA viral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Efficiency of VIGS and gene expression in a novel bipartite potexvirus vector delivery system as a function of strength of TGB1 silencing suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

High-efficiency protein expression in plants from agroinfection-compatible Tobacco mosaic virus expression vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

TRBO: a high-efficiency tobacco mosaic virus RNA-based overexpression vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

The amplicon-plus system for high-level expression of transgenes in plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Efficient production of chimeric human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Anti-cancer activity of plant-produced HPV16 E7 vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

A plant-produced influenza subunit vaccine protects ferrets against virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

High-yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

A launch vector for the production of vaccine antigens in plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

A human papillomavirus 8 E7 protein produced in plants is able to trigger the mouse immune system and delay the development of skin lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Plant-made pharmaceuticals: leading products and production platforms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Plant-made vaccines in support of the Millennium Development Goals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Bovine herpes virus gD protein produced in plants using a recombinant tobacco mosaic virus (TMV) vector possesses authentic antigenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Plant-produced vaccines: promise and reality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Plant-made vaccines for humans and animals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Production of dengue 2 envelope domain III in plant using TMV-based vector system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Extremely high-level and rapid transient protein production in plants without the use of viral replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Rapid transient production in plants by replicating and non-replicating vectors yields high quality functional anti-HIV antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Cowpea mosaic virus: the plant virus-based biotechnology workhorse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Pharma-Planta: road testing the developing regulatory guidelines for plant-made pharmaceuticals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Malarial epitopes expressed on the surface of recombinant tobacco mosaic virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Plant virus expression systems for transient production of recombinant allergens in Nicotiana benthamiana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Production and characterization of an orally immunogenic Plasmodium antigen in plants using a virus-based expression system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.06.012

10.1016/J.VIROL.2012.06.012

7 January 2021

Identifiers

DOI

1 reference

release_qqwvtktgcvcpjp3ab3scsk4ale

27 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qqwvtktgcvcpjp3ab3scsk4ale

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference